results

TScan Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Presented positive updated data from the ALLOHA™ Phase 1 heme trial at 67th American Society of Hematology (ASH) Annual Meeting…

13 hours ago

Kamada to Announce Fiscal Year and Fourth Quarter 2025 Financial Results on March 11, 2026

Company to Host Conference Call at 8:30am ET March 04, 2026 07:00 ET  | Source: Kamada Ltd. REHOVOT, Israel, and…

13 hours ago

Fate Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates

Outpatient treatment enabled under FT819-102 autoimmune basket protocol with patients now treated with FT819 off-the-shelf CAR T-cell therapy as same-day…

6 days ago

THE ADECCO GROUP Q4 & FULL YEAR 2025 RESULTS

Strong share gains and solid growth; operating leverage and cashflow drive deleveragingZURICH, Feb. 25, 2026 /PRNewswire/ -- AD HOC ANNOUNCEMENT…

7 days ago

Cardiff Oncology Reports Full Year 2025 Results and Provides Business Update

February 24, 2026 16:30 ET  | Source: Cardiff Oncology, Inc. Reported positive update from Phase 2 CRDF-004 trial in first-line…

1 week ago

Constellation Software Inc. Announces Change to the Date of the Conference Call to Discuss Fourth Quarter Results

February 20, 2026 17:16 ET  | Source: Constellation Software Inc. TORONTO, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Constellation Software Inc.…

2 weeks ago

Amicus Therapeutics Announces Full-Year 2025 Financial Results and Corporate Updates

2025 Total Revenue of $634M, up 17% Year-over-Year at CER Cash Position of $294M, a $44M Increase in 2025 Proposed…

2 weeks ago

GigaCloud Technology Inc to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on February 26, 2026

February 19, 2026 08:05 ET  | Source: GigaCloud Technology EL MONTE, Calif., Feb. 19, 2026 (GLOBE NEWSWIRE) -- GigaCloud Technology…

2 weeks ago

NSA Labs Helps Leading Biopharmaceutical Companies Get Study Results Faster on Proscias Platform

Specialized CRO has delivered 750 neuroscience studies advancing drug R&D with digital pathology February 17, 2026 08:00 ET  | Source:…

2 weeks ago

Inventiva reports preliminary 2025 fiscal year financial results

Cash and cash equivalents at €99.3 million, and €131.6 million in short-term deposits2 as of December 31, 2025Revenues of €4.5…

2 weeks ago